Meetings

This page is for members only. To view it, please enter your password below:
Password:

New EU wide project aims to reduce prostate cancer mortality while avoiding overdiagnosis and overtreatment through smart early detection.
ERSPC latest findings confirm increased mortality benefit from prostate cancer testing
PSA screening cuts deaths by 20%, says world’s largest prostate cancer study

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer
From screening to mortality reduction: an overview of emperical data on the patient journey in European Randomized Study of Screening for Prostate Cancer Rotterdam after 21 years of follow-up and a reflection on quality of life
Prostate cancer mortality among elderly men after discontinuing organised screening: long-term results from the European Randomized Study of Screening for Prostate Cancer Rotterdam